North East Health, Biotech & Nutrition R&D Companies Directory

The Newcastle upon Tyne Hospitals NHS Foundation Trust is a leading UK healthcare provider that actively integrates advanced medical research into clinical practice. Their work focuses on the translation of innovative technologies—including artificial intelligence, digital pathology, and advanced cell and gene therapies—into patient-centred care pathways. Through extensive collaboration with industry and academia, the Trust bridges the gap between fundamental research and real-world clinical application.

IBEX Innovations is a micro enterprise in the North East of England that develops physics-based X-ray imaging technologies, including virtual anti-scatter grids and materials classification. Their work has evolved from prototype dose-reduction detectors to commercial products like IBEX Trueview, an AI-assisted bone health screening software that uses standard radiographs to diagnose osteoporosis. They serve medical diagnostic and food safety markets, with a strong track record of leading Innovate UK projects.

ScubaTx develops an automatic organ-care system using advanced temperature control and persufflation (oxygenated air) to extend the preservation time of donor organs from hours to 24 hours or longer, enabling more transplants and reducing organ wastage. The company has evolved from early R&D on organ preservation to pre-commercialisation design, a lung-specific product line, and integration with drone logistics for rapid organ transport.

Arcinova is a contract development and manufacturing organisation specialising in pharmaceutical services, including drug substance and drug product development. Their work has evolved from implementing digital robotics for flexible medicine production to leading life-cycle environmental assessments and developing sustainable, scalable RNA-manufacturing platforms. They provide integrated solutions to the pharmaceutical industry, focusing on enhancing manufacturing efficiency and reducing the environmental footprint of therapeutic production.

Nanovery is a biotechnology company specialising in DNA nanorobotics for diagnostic and drug development applications. The company has developed a platform using nucleic acid nanorobots (NANs) to detect cancer biomarkers in liquid biopsies and to measure oligonucleotide therapeutics, progressing from basic biosensor research to applying machine learning to accelerate nanorobot design.

LightOx is a drug development company based in Newcastle upon Tyne, specialising in light-activated molecules for biological imaging and therapy. Their products, known as LightOx Probes, enable fluorescence and Raman imaging of cells, and they are developing antimicrobial treatments for chronic wounds and light-activated therapy for oral epithelial dysplasia to prevent oral cancer. Their work spans from fundamental probe characterisation to clinical-grade prototype development and market access planning.

Nunabio is a North East-based biotechnology company specialising in DNA detection and synthesis technologies. Their patented oligoseed amplification method aims to replace traditional solid-phase phosphoramidite chemistry, enabling scalable, environmentally sustainable DNA production for cell and gene therapies, molecular diagnostics, and pathogen detection. The company has progressed from developing DNA detection platforms to pioneering scalable DNA synthesis processes through a series of Innovate UK grants.

Iksuda Therapeutics (formerly Glythera) is a biotechnology company specialising in the development of antibody-drug conjugates (ADCs) for cancer therapy. Their work centres on improving the therapeutic index of ADCs through proprietary PermaLink conjugation chemistry, which enhances stability and tumour targeting. The company has progressed from early feasibility studies on glycosylation to advanced ADC design aimed at hard-to-treat cancers.

Quotient Clinical is a specialist pharmaceutical services provider focused on streamlining drug substance manufacturing through the development of flexible, modular technology platforms. Their work addresses the industry shift towards complex, potent small molecule drugs by enabling efficient, low-inventory, and high-purity manufacturing processes. They integrate advanced chemical engineering with pharmaceutical development to reduce waste and improve throughput for targeted treatments.

PulmoBioMed is a medical diagnostics company developing a non-invasive breath sampling device (PBM-HALE) that captures exhaled biomarkers for disease detection. Their technology evolved from initial device development in 2021 to clinical validation in 2022, aiming to classify asthma and pneumonia causes. They focus on standardised breath collection for multi-analyte analysis to replace invasive procedures.

Industrial Technology Systems is a specialist engineering firm focused on advanced process control and real-time measurement solutions for the food and drink manufacturing sector. Their work centres on integrating sophisticated sensing and data-driven control systems to optimise production lines and mitigate chemical contaminants. The company has demonstrated a consistent focus on technical innovation within the food supply chain, leveraging collaborative research to address complex industrial safety and quality challenges.

Atelerix develops a proprietary hydrogel-based technology for preserving living cells and biological samples at room temperature, extending their functional viability without freezing. The company applies this technology to cell therapies, diagnostic samples, tissue biopsies, and agricultural germplasm, aiming to simplify cold-chain logistics and expand access to biological materials. Their work has evolved from feasibility studies to commercial product development for clinical and research applications.

XR Therapeutics is a spin-out from Newcastle University that delivers virtual reality therapy for mental health conditions. Combining cognitive behavioural therapy with immersive VR, the company treats phobias, anxiety, and self-harm, shortening traditional treatment from 12-20 sessions to as few as one. The company has established commercial relationships with NHS trusts and private health insurers.

Active Families NE is a social enterprise based in the North East of England that focuses on improving the health and wellbeing of vulnerable older populations. They develop and deploy mobile outreach services, specifically their 'Well-bean Machine' van, to deliver physical activity interventions and social support directly into communities experiencing high levels of deprivation. Their work has evolved from initial pilot interventions to a scaled-up service delivery model aimed at reducing health inequalities and alleviating pressures on local social care systems.

Apperta Foundation is a UK-based non-profit that develops open digital standards and platforms for healthcare, focusing on interoperability and improving patient outcomes. Their work includes creating an open standard electronic observation (eObs) system for deteriorating patient care and a telemedicine solution that connects directly to patient records, both aimed at reducing NHS reliance on proprietary systems.

Epigem is a polymer micro engineering company specialising in microfluidics, electrodes, and optics. They develop devices for medical applications, including heart arrhythmia treatment and rapid infectious disease diagnosis, and have evolved from early innovation to leading a UK-China collaboration on antimicrobial resistance diagnostics.

Health Innovation North East and North Cumbria is a regional NHS innovation network that coordinates the delivery of advanced therapies and supports the adoption of new health technologies across Scotland and Northern England. Their work spans establishing treatment centres for cell and gene therapies, running a FemTech accelerator, and leading a data-driven patient stratification project for rheumatic diseases using routine clinical data.

PolyPhotonix develops flexible light-emitting devices and photonic medical technologies, initially targeting fast-moving consumer goods and later shifting to a non-invasive sleep mask for diabetic retinopathy. Their work spans from manufacturing readiness of light-emitting electrochemical cells to clinical evaluation of the Noctura 400 device.

CPI Innovation Services is a medium-sized contract research and innovation organisation based in North East England. The company specialises in process analytical technologies for biopharmaceutical manufacturing, microbial fermentation for sustainable food ingredients, and regulatory science frameworks for digitalisation and in-silico methods in life sciences. Their work spans from developing multiplexed spectroscopic tools for freeze-drying to establishing standards for automated medicine manufacture.

Aelius Biotech specialises in developing laboratory models of the human digestive tract, particularly the large intestine, for research and personalised medicine. The company's work spans from scaling production of an integrated colon model to collaborating on low-cost growth factor alternatives for cultivated meat, reflecting a move from biomedical research into sustainable food production.